Coverage and effectiveness of conditional cash transfer for people with drug resistant tuberculosis in Zimbabwe: a mixed methods study

Author:

Timire CollinsORCID,Sandy CharlesORCID,Ferrand Rashida A,Mubau Regina,Shiri Peter,Mbiriyawanda Obert,Mbiba FredrickORCID,Houben Rein MGJ,Pedrazzoli Debora,Bond Virginia,Foster Nicola,Kranzer Katharina

Abstract

AbstractBackgroundThe End TB strategy recommends social protection to mitigate socio-economic impacts of tuberculosis. Zimbabwe started implementing a conditional cash transfer (CCT) programme for people on drug resistant tuberculosis (DR-TB) treatment in 2013. We aimed to determine the proportion of people receiving CCT and effectiveness of CCT in improving treatment outcomes, explore their experiences with registering for CCT and understand the impact of CCT from the perspective of beneficiaries.MethodsData from 2014-2021 were extracted from TB registers and CCT payment records within the National TB Programme. Sixteen in-depth interviews were conducted with people who were completing treatment or had completed treatment within two months. Poisson regression, adjusted for province, year of treatment, age and sex was used to investigate associations between receiving CCT and successful treatment outcomes among people who were in DR-TB care for ≥3 months after treatment initiation. Qualitative data were analyzed using thematic analysis.ResultsA total of 481 people were included in the quantitative study. Of these, 53% (254/481) received CCT at some point during treatment. People who exited DR-TB care within three months were 73% less likely to receive CCT than those who did not (prevalence ratio (PR)=0.27 [95%CI: 0.18-0.41]). Among those who were alive and in care three months after treatment initiation, CCT recipients were 32% more likely to have successful outcomes than those who did not (adjusted PR=1.32, [95%CI: 1.00-1.75]). Qualitative results revealed lack of knowledge about availability of CCT among people with DR-TB and missed opportunities by healthcare providers to provide information about availability of CCT. Delays and inconsistencies in disbursements of CCT were frequent themes.ConclusionCCT were associated with successful treatment outcomes. Improvements in coverage, timeliness and predictability of disbursements are recommended.

Publisher

Cold Spring Harbor Laboratory

Reference40 articles.

1. World Health Organisation. Global TB Report 2021 [Internet]. Geneva, Switzerland; 2021. Available from: https://www.who.int/publications/i/item/9789240037021

2. World Health Organisation. Global Tuberculosis Report 2020. Geneva, Switzerland; 2020.

3. World Health Organisation. Global Tuberculosis Report 2019 [Internet]. Geneva, Switzerland; 2019. Available from: WHO/CDS/TB/2019.15

4. World Health Organisation. Global Tuberculosis Report 2018 [Internet]. Geneva, Switzerland; 2018. Available from: WHO/CDS/TB/2018.20

5. STOP TB Partnership. The paradigm shift 2016-2020: Global plan to End TB [Internet]. Geneva, Switzerland; 2015. Available from: http://www.stoptb.org/global/plan/plan2/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3